Back to Resource Center

Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake

Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake

View Journal Article

Uptake of oral pre-exposure prophylaxis (PrEP) remains low. The objective of this analysis was to estimate the potential market size in priority sub-Saharan African countries for a 28-day dual prevention pill (DPP) regimen containing the active pharmaceutical ingredients in oral PrEP and oral contraceptive pills (OCPs) for the prevention of HIV and unintended pregnancy.

July 2021

Click to view Journal Article

Click for full info +

Full Info:


Resource Type:

Journal Article

Citation:

Uptake of oral pre-exposure prophylaxis (PrEP) remains low. The objective of this analysis was to estimate the potential market size in priority sub-Saharan African countries for a 28-day dual prevention pill (DPP) regimen containing the active pharmaceutical ingredients in oral PrEP and oral contraceptive pills (OCPs) for the prevention of HIV and unintended pregnancy.

Authors:

Lorna Begg, Rebecca Brodsky, Barbara Friedland, Sanyukta Mathur, Jim Sailer, George Creasy

Health Risks(s):

  • HIV
  • Unintended Pregnancy

Product type(s):

  • MPTs

Topic(s):

  • MPTs
  • Development
  • Reproductive Health
  • Social

Region(s)

  • Africa

URL of resource:

https://pubmed.ncbi.nlm.nih.gov/32737137/

Back to Resource Center